Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev CloseN/A
BidN/A x N/A
AskN/A x N/A
52wk Rangeundefined - undefined
Day's RangeN/A - N/A
Avg Vol (3m)N/A
  • Bloomberglast year

    Mallinckrodt’s Questcor Said Facing Multistate Antitrust Probe

    Mallinckrodt Plc’s Questcor Pharmaceuticals Inc. faces a multistate antitrust investigation, according to a Texas attorney general’s office letter revealing that state’s participation in the probe. Texas said that, as of last month, it “anticipated being involved” in the multistate case, according to the June 12 letter, a response to a freedom of information request in May. Katherine Wise, a spokeswoman for Texas Attorney General Ken Paxton, authenticated the letter while declining to comment further on the probe.

  • Zackslast year

    Mallinckrodt Tops Q2 Earnings & Revenues on Acquisitions - Analyst Blog

    Mallinckrodt plc (MNK) reported adjusted earnings of $1.72 per share in the second quarter of fiscal 2015 easily beating the Zacks Consensus Estimate of $1.48.